Table 5.
Effect of S/P-based IPTp target dosing in primigravid mothers and their newborns: analysis and comparison between no bed net and bed net used groups in the Kassena Nankana District, northeastern Ghana*
| Characteristic | Primigravidae, no bed net | Primigravidae, bed net used | ||||
|---|---|---|---|---|---|---|
| No IPTp | IPTp target met | P | No IPTp | IPTp target met | P | |
| Number | 50 | 101 | 36 | 92 | ||
| Mother's age, years, mean ± 95% CI | 20.09 ± 0.8 | 20.87 ± 0.62 | NS | 20.01 ± 0.89 | 20.93 ± 0.64 | NS |
| Mother's education, years, mean ± 95% CI | 4.9 ± 1.08 | 5.99 ± 0.90 | NS | 5.00 ± 1.3 | 6.86 ± 0.94 | 0.02 |
| ANC clinic visits, mean ± 95% CI | 3.38 ± 0.66 | 5.93 ± 0.35 | < 0.001 | 3.50 ± 0.80 | 6.1 ± 0.43 | < 0.001 |
| Pre-term births (%) | 2/50 (4) | 1/101 (1) | NS | 3/36 (8.3) | 1/92 (1.1) | NS |
| Birth weight, kg, mean ± 95% CI | 2.69 ± 0.12 | 2.74 ± 0.09 | NS | 2.55 ± 0.16 | 2.73 ± 0.09 | 0.05 |
| Underweight births (< 2,500 grams) (%) | 16/50 (32) | 25/101 (24.7) | NS | 16/36 (44.4) | 21/92 (22.8) | 0.015 |
| Hb (g/dL) at birth, mean ± 95% CI | 13.72 ± 0.59 | 14.59 ± 0.49 | 0.03 | 14.46 ± 1.01 | 14.42 ± 0.39 | NS |
| Neonatal anemia (Hb < 11.0 g/dL) (%) | 4/44 (9.1) | 5/91 (5.5) | NS | 2/26 (7.7) | 1/86 (1.2) | NS |
| Fetal anemia (Hb < 12.5 g/dL) (%) | 10/44 (22.7) | 13/91 (14.3) | NS | 6/26 (23.1) | 8/86 (9.3) | 0.088 |
| All-cause infant death by 20–33 months) (%) | 4/50 (8) | 4/101 (4) | NS | 2/36 (5.5) | 7/92 (7.6) | NS |
*
IPTp = intermittent preventive treatment; CI = confidence interval; NS = not significant; Hb = hemoglobin.